Molecular epidemiology of Aspergillus fumigatus in chronic pulmonary aspergillosis patients

Mireille H. van der Torre, Hongwei Shen, Riina Rautemaa-Richardson , Malcolm Richardson, Lily Novak Frazer

Research output: Contribution to journalArticlepeer-review


Molecular fungal genotyping techniques developed and employed for epidemiological studies have understandably concentrated on establishing the genetic diversity of Aspergillus fumigatus in invasive aspergillosis due to its severity, the urgency for treatment, as well as the need to demonstrate possible sources. Some early studies suggested that these strains were phenotypically, if not genotypically, different from others. However, with improved discrimination and evaluations, incorporating environmental as well as clinical isolates from other Aspergillus conditions (e.g., chronic pulmonary aspergillosis and cystic fibrosis), this premise is no longer upheld. Moreover, with the onset of increased global triazole resistance, there has been a concerted effort to incorporate resistance profiling into genotyping studies and realisation that the wider population of non-immunocompromised aspergillosis patients are at risk. This review summarises the developments in molecular genotyping studies that incorporate resistance profiling with attention to chronic pulmonary aspergillosis and an example of our UK experience.
Original languageEnglish
JournalJournal of Fungi
Publication statusAccepted/In press - 15 Feb 2021


Dive into the research topics of 'Molecular epidemiology of Aspergillus fumigatus in chronic pulmonary aspergillosis patients'. Together they form a unique fingerprint.

Cite this